(Q35555433)

English

Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus

scientific article published on April 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

methylprednisolone

1 reference

based on heuristic

inferred from title

systemic lupus erythematosus

0 references

author name string

Barile-Fabris L

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Ariza-Andraca R

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Olguín-Ortega L

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Jara LJ

4

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Fraga-Mouret A

5

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Miranda-Limón JM

6

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Fuentes de la Mata J

7

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Clark P

8

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Vargas F

9

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Alocer-Varela J

10

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

language of work or name

0 references

publication date

1 April 2005

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

64

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

620-625

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Central nervous system lupus: a clinical approach to therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755456

12 July 2018

Endothelium and the brain in CNS lupus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755456

12 July 2018

APS and the brain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755456

12 July 2018

The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755456

12 July 2018

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755456

12 July 2018

Cyclophosphamide versus methylprednisolone for the treatment of neuropsychiatric involvement in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755456

12 July 2018

A conceptual framework for clinical trials in SLE and other multisystem diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755456

12 July 2018

Successful treatment of systemic lupus erythematosus cerebritis with intravenous immunoglobulin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755456

12 July 2018

Anti beta2-glycoprotein I antibodies: clinical significance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755456

12 July 2018

Transverse myelopathy in SLE: clinical features and functional outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755456

12 July 2018

The antiphospholipid/cofactor syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755456

12 July 2018

Interim analyses, stopping rules and data monitoring in clinical trials in Europe

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755456

12 July 2018

Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755456

12 July 2018

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755456

12 July 2018

Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755456

12 July 2018

Pulse Cyclophosphamide for Severe Neuropsychiatric Lupus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755456

12 July 2018

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755456

12 July 2018

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755456

12 July 2018

Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755456

26 September 2018

The association between the antiphospholipid antibody syndrome and neuropsychological impairment in SLE.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755456

26 September 2018

Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate

1 reference

https://pubmed.ncbi.nlm.nih.gov/15769918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/15769918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15769918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment with anti-CD20 monoclonal antibody (rituximab) of life-threatening refractory systemic lupus erythematosus with renal and central nervous system involvement

1 reference

https://pubmed.ncbi.nlm.nih.gov/15769918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperviscosity syndrome as the initial manifestation of systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/15769918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment combining plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/15769918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electroconvulsive therapy and cyclophosphamide in combination for severe neuropsychiatric lupus with catatonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15769918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Study duration for clinical trials with survival response and early stopping rule

1 reference

https://pubmed.ncbi.nlm.nih.gov/15769918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transverse myelitis in systemic lupus erythematosus--the effect of IV pulse methylprednisolone and cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/15769918

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ARD.2004.025528

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35555433&oldid=1615944228"